Suppr超能文献

巨细胞病毒感染极低出生体重儿的发生率和影响。

Incidence and impact of CMV infection in very low birth weight infants.

机构信息

Divisions of Neonatology, and.

出版信息

Pediatrics. 2014 Mar;133(3):e609-15. doi: 10.1542/peds.2013-2217. Epub 2014 Feb 2.

Abstract

BACKGROUND AND OBJECTIVES

Congenital cytomegalovirus (CMV) is the leading cause of nongenetic deafness in children in the United States and can cause neurodevelopmental impairment in term infants. Limited data exist regarding congenital CMV infections in preterm infants. We aimed to determine the incidence and association with outcomes of congenital CMV in very low birth weight (VLBW) preterm infants.

METHODS

VLBW infants born in 1993 to 2008 and admitted to the University of Alabama in Birmingham Regional Neonatal ICU were screened on admission for congenital CMV. CMV status and clinical outcomes were identified by using internal patient databases and hospital-based medical records. The primary outcome was death. Secondary outcomes included evidence of neurologic injury in the form of abnormal cranial ultrasound findings, sensorineural hearing loss, or abnormal motor development. Multivariate analysis was performed.

RESULTS

Eighteen of 4594 VLBW infants had congenital CMV (0.39%; 95% confidence interval, 0.25%-0.62%). An additional 16 infants (0.35%; 95% confidence interval, 0.21%-0.57%) were identified who acquired CMV postnatally. Congenital CMV was not associated with death. Compared with controls, congenitally infected VLBW infants were more likely to have hearing loss at initial screening (67% vs. 9%, P < .0001) and confirmed at follow-up (83% vs. 2.1%, P < .0001). Congenital CMV was also associated with abnormal neuroimaging (72% vs. 25%, P < .0001) and adverse developmental motor outcomes (43% vs. 9%, P = .02). Acquired CMV was not associated with any adverse outcomes.

CONCLUSIONS

Congenital CMV in VLBW infants is associated with high rates of neurologic injury and hearing loss but not death.

摘要

背景和目的

先天性巨细胞病毒(cytomegalovirus,CMV)是美国儿童非遗传性耳聋的主要原因,并且可导致足月婴儿的神经发育障碍。关于早产儿先天性 CMV 感染的数据有限。我们旨在确定极低出生体重(very low birth weight,VLBW)早产儿中先天性 CMV 感染的发生率及其与结局的关系。

方法

1993 年至 2008 年在阿拉巴马大学伯明翰分校地区新生儿重症监护病房出生并入院的 VLBW 婴儿在入院时接受先天性 CMV 筛查。通过内部患者数据库和医院病历确定 CMV 状态和临床结局。主要结局为死亡。次要结局包括异常头颅超声发现、感觉神经性听力损失或运动发育异常等神经损伤证据。进行了多变量分析。

结果

4594 例 VLBW 婴儿中有 18 例(0.39%;95%置信区间,0.25%-0.62%)患有先天性 CMV。另外还有 16 例(0.35%;95%置信区间,0.21%-0.57%)婴儿在出生后获得了 CMV。先天性 CMV 与死亡无关。与对照组相比,先天性感染的 VLBW 婴儿在初次筛查时更有可能出现听力损失(67%比 9%,P<0.0001),在随访时也更有可能出现听力损失(83%比 2.1%,P<0.0001)。先天性 CMV 还与异常神经影像学(72%比 25%,P<0.0001)和不良发育运动结局(43%比 9%,P=0.02)相关。获得性 CMV 与任何不良结局均无关。

结论

VLBW 婴儿的先天性 CMV 与较高的神经损伤和听力损失发生率相关,但与死亡率无关。

相似文献

1
Incidence and impact of CMV infection in very low birth weight infants.
Pediatrics. 2014 Mar;133(3):e609-15. doi: 10.1542/peds.2013-2217. Epub 2014 Feb 2.
3
Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants.
Pediatr Infect Dis J. 2004 Apr;23(4):322-7. doi: 10.1097/00006454-200404000-00009.
4
A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening.
Pediatrics. 2017 Feb;139(2). doi: 10.1542/peds.2016-2128. Epub 2017 Jan 3.
5
Hearing outcome in congenitally CMV infected children in Finland - Results from follow-up after three years age.
Int J Pediatr Otorhinolaryngol. 2022 May;156:111099. doi: 10.1016/j.ijporl.2022.111099. Epub 2022 Mar 3.
7
Audiological outcome of infants with congenital cytomegalovirus infection in a prospective study.
Audiol Neurootol. 2007;12(1):31-6. doi: 10.1159/000096156. Epub 2006 Oct 10.
8
Follow-up of infants with congenital cytomegalovirus and normal fetal imaging.
Arch Dis Child Fetal Neonatal Ed. 2016 Sep;101(5):F428-32. doi: 10.1136/archdischild-2015-308357. Epub 2016 Jan 18.
10
Congenital cytomegalovirus infection: an overview.
Infect Disord Drug Targets. 2011 Oct;11(5):432-6. doi: 10.2174/187152611797636712.

引用本文的文献

1
Drug Incompatibilities and Complex Assemblies: Let Us Remain Vigilant!
Pharmaceuticals (Basel). 2025 Apr 25;18(5):626. doi: 10.3390/ph18050626.
2
Dosing, Toxicity and Drug Concentrations for Ganciclovir/Valganciclovir in Preterm and Low Birthweight Infants Treated for Cytomegalovirus.
Pediatr Infect Dis J. 2025 Apr 1;44(4):319-325. doi: 10.1097/INF.0000000000004605. Epub 2024 Nov 13.
3
Lissencephaly and Advanced-Stage Congenital Cytomegalovirus Infection in a Neonate.
Cureus. 2024 Jun 3;16(6):e61576. doi: 10.7759/cureus.61576. eCollection 2024 Jun.
4
Association between viral infection and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
Eur J Pediatr. 2024 Jul;183(7):2965-2981. doi: 10.1007/s00431-024-05565-9. Epub 2024 Apr 18.
6
Congenital cytomegalovirus infection: the state of the art and future perspectives.
Front Pediatr. 2023 Nov 16;11:1276912. doi: 10.3389/fped.2023.1276912. eCollection 2023.
7
Early childhood outcomes of NICU graduates with cytomegalovirus infection in California.
Birth Defects Res. 2023 Jun 15;115(11):1093-1100. doi: 10.1002/bdr2.2203. Epub 2023 May 25.
9
Treatment of Congenital Cytomegalovirus and Ganciclovir Therapeutic Drug Monitoring in Twin Preterm Infants.
J Pediatr Pharmacol Ther. 2023;28(1):93-101. doi: 10.5863/1551-6776-28.1.93. Epub 2023 Feb 3.
10
Microelectromechanical system-based biosensor for label-free detection of human cytomegalovirus.
IET Nanobiotechnol. 2023 Feb;17(1):32-39. doi: 10.1049/nbt2.12109. Epub 2022 Dec 20.

本文引用的文献

1
Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.
N Engl J Med. 2012 Dec 27;367(26):2495-504. doi: 10.1056/NEJMoa1208506.
2
Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009.
Pediatrics. 2012 Jun;129(6):1019-26. doi: 10.1542/peds.2011-3028. Epub 2012 May 21.
3
Hearing in preterm infants with postnatally acquired cytomegalovirus infection.
Pediatr Infect Dis J. 2012 Oct;31(10):1082-4. doi: 10.1097/INF.0b013e31825eb3e5.
4
Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk.
Acta Paediatr. 2012 Apr;101(4):e167-72. doi: 10.1111/j.1651-2227.2011.02538.x. Epub 2011 Dec 23.
5
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
N Engl J Med. 2011 Jun 2;364(22):2111-8. doi: 10.1056/NEJMoa1006561.
7
Transmission of cytomegalovirus via breast milk in extremely premature infants.
J Perinatol. 2011 Jun;31(6):440-5. doi: 10.1038/jp.2010.150. Epub 2010 Dec 16.
8
Congenital cytomegalovirus infection: treatment, sequelae and follow-up.
J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:45-8. doi: 10.3109/14767058.2010.506753.
10
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.
J Clin Virol. 2009 Dec;46 Suppl 4(Suppl 4):S22-6. doi: 10.1016/j.jcv.2009.08.012. Epub 2009 Sep 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验